IN CLINICAL Research Articles

732 VISCERAL OBESITY AND RISK OF HIGH-GRADE DISEASE IN CLINICAL T1A RENAL CELL CARCINOMA

You have accessJournal of UrologyKidney Cancer: Evaluation & Staging (II)1 Apr 2013732 VISCERAL OBESITY AND RISK OF HIGH-GRADE DISEASE IN CLINICAL T1A RENAL CELL CARCINOMA Yao Zhu, Hong-Kai Wang, and Ding-Wei Ye Yao ZhuYao Zhu Shanghai, China, People's Republic of More articles by this author , Hong-Kai WangHong-Kai Wang Shanghai, China, People's Republic of More articles by this author , and Ding-Wei YeDing-Wei Ye Shanghai, China, People's Republic of More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2013.02.295AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Accurate assessment of disease characteristics is a prerequisite for treatment decision making in small renal masses. The aim of the current study was to evaluate the association between visceral obesity and Fuhrman grade (FG) in patients with cT1a renal cell carcinoma (RCC). METHODS We retrospectively collected data on 186 patients with surgically treated cT1a RCC. Single-slice computed tomography images were used to measure the area of visceral and subcutaneous adipose tissue. Visceral obesity was calculated as the proportion of visceral adipose tissue to overall adipose tissue (VAT%). Other analyzed factors included clinical characteristics (age, gender, body mass index and tumor size) and anatomic features of the tumor defined by RENAL nephrometry score. The association between predictors and high-grade disease (FG III or IV) were assessed using logistic regression analyses. RESULTS Fourty-seven (25.3%) tumors were classified as high-grade. VAT% was higher in male participants, but didn't correlate with body mass index, age or tumor size. In univariate analyses, VAT% and tumor size were significantly associated with higher FG. Multivariate analysis showed that VAT% (odds ratio=1.06, p=0.0018) and tumor size (odds ratio=1.91, p=0.047) were independent predictors of high-grade cancer. Addition of VAT% to a model including clinical characteristics and anatomic features of the tumor remarkably improved its discriminatory ability (p=0.0010). CONCLUSIONS Increased visceral obesity was found to be strongly associated with higher FG in patients with cT1a RCC. Further studies are needed to confirm these findings and discover the underlying biological mechanism. © 2013 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 189Issue 4SApril 2013Page: e301 Advertisement Copyright & Permissions© 2013 by American Urological Association Education and Research, Inc.MetricsAuthor Information Yao Zhu Shanghai, China, People's Republic of More articles by this author Hong-Kai Wang Shanghai, China, People's Republic of More articles by this author Ding-Wei Ye Shanghai, China, People's Republic of More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...

O435 THE REAL: SRH MULTIPURPOSE PREVENTION TECHNOLOGIES IN CLINICAL DEVELOPMENT

International Journal of Gynecology & ObstetricsVolume 119, Issue S3 p. S415-S416 Free communication (oral) presentations O435 THE REAL: SRH MULTIPURPOSE PREVENTION TECHNOLOGIES IN CLINICAL DEVELOPMENT J. Manning, J. ManningSearch for more papers by this author J. Manning, J. ManningSearch for more papers by this author First published: 22 October 2012 https://doi.org/10.1016/S0020-7292(12)60865-0AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article. Volume119, IssueS3Abstracts of XX FIGO World Congress of Gynecology and ObstetricsOctober 2012Pages S415-S416 RelatedInformation

265 NUCLEAR FRAGMENTATION IN CLINICAL HEAVY ION BEAMS, SHOULD WE WORRY?

265 NUCLEAR FRAGMENTATION IN CLINICAL HEAVY ION BEAMS, SHOULD WE WORRY? N. Bassler, A. Luhr, J. Toftegaard, D.C. Hansen, R. Teiwes, N. Sobolevsky, O. Jakel, R. Herrmann Dept. of Experimental Clinical Oncology, Aarhus University, Denmark Dept. of Physics and Astronomy, Aarhus University, Denmark Dept. of Computer Science, Aarhus University, Denmark Inst. of Nuclear Research RAS, Moscow, Russia German Cancer Research Center, Heidelberg, Germany

Effect of external use of sesame oil in the prevention of chemotherapy-induced phlebitis.

Intravenous chemotherapy is an important mean for the treatment of cancers. Infusion phlebitis (Ph) is a common and acute complication of chemotherapy. The frequency of Ph is about 70% in patients undergoing chemotherapeutic management. It can induce the pain, increase the risk of thrombophlebitis, lead to incomplete follow-up, and thereby, affect the patient's health status. Respecting the great importance of these issues, it is essential to prevent Ph. This study conducted to determine the effect of external use of Sesame Oil (SO) in the prevention of Ph. SIXTY PATIENTS WITH COLON OR RECTUM CANCER, WHO ADMITTED FOR CHEMOTHERAPEUTIC MANAGEMENT, ENROLLED IN CLINICAL TRIAL AND WERE RANDOMLY DIVIDED INTO TWO EQUAL GROUPS: Control and Intervention. Ten drops of SO was applied twice a day for 14 days externally in intervention group, whereas the control group received nothing. Incidence and grade of Ph was measured in both groups. Data was analyzed through independent t-test, Χ2, Fisher's exact test, Mann-Whitney, and Lagrange survival using SPSS 16. The incidence of Ph was 10% and 80% in intervention group and control group, respectively.There was a significant difference between two groups (p < 0.05). Ph was 8 times more frequent in control group (R R = 8; AR R = 70%). In addition, there was statistically significant difference between the grade and incidence of Ph with SO and control group (p < 0.05). According to these results, it seems that external use of SO is effective, safe and well-tolerated for prophylaxis from Ph. Therefore, it can be suggested as a selected prevention method for reducing the complication.

THE PRACTICAL IMPORTANCE OF THEORY IN CLINICAL ETHICS SUPPORT SERVICES

BioethicsVolume 25, Issue 7 p. ii-iii THE PRACTICAL IMPORTANCE OF THEORY IN CLINICAL ETHICS SUPPORT SERVICES BERT MOLEWIJK, Corresponding Author BERT MOLEWIJK Department of Medical Humanities, EMGO+ Institute, VU University Medical Centre, Amsterdam, and institute for Mental Health Care in ZutphenBert Molewijk, Rm. D324, Dep. Medical Humanities (Division VI), Van der Boechorst straat 7, 1081 BT, Amsterdam, NL. E-mail: [email protected]Search for more papers by this authorANNE SLOWTHER, ANNE SLOWTHER Warwick Medical SchoolSearch for more papers by this authorMARK AULISIO, MARK AULISIO Department of Bioethics at Case, and the Centre for Biomedical Ethics at MetroHealth Medical Centre (Cleveland, Ohio)Search for more papers by this author BERT MOLEWIJK, Corresponding Author BERT MOLEWIJK Department of Medical Humanities, EMGO+ Institute, VU University Medical Centre, Amsterdam, and institute for Mental Health Care in ZutphenBert Molewijk, Rm. D324, Dep. Medical Humanities (Division VI), Van der Boechorst straat 7, 1081 BT, Amsterdam, NL. E-mail: [email protected]Search for more papers by this authorANNE SLOWTHER, ANNE SLOWTHER Warwick Medical SchoolSearch for more papers by this authorMARK AULISIO, MARK AULISIO Department of Bioethics at Case, and the Centre for Biomedical Ethics at MetroHealth Medical Centre (Cleveland, Ohio)Search for more papers by this author First published: 26 July 2011 https://doi.org/10.1111/j.1467-8519.2011.01917.xCitations: 6Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article.Citing Literature Volume25, Issue7Special Issue: Clinical ethics support services: theory, method, and practiceSeptember 2011Pages ii-iii RelatedInformation

ANCILLARY STUDIES IN CLINICAL TRIALS (R01): RFA-HL-12-012

ANCILLARY STUDIES IN CLINICAL TRIALS (R01): RFA-HL-12-012

Commentary: Call for a Quality Standard for Sequence-Based Assays in Clinical Microbiology: Necessity for Quality Assessment of Sequences Used in Microbial Identification and Typing

Subsequent to the early days of radioisotope sequencing, DNA sequencing technologies have evolved rapidly, giving rise to techniques that are more sensitive and rapid and provide longer sequence reads. These incremental improvements in technology and in the automation of modern sequencing platforms have resulted in applications of DNA sequencing across virtually all biological science disciplines. In microbiology, this has led to a significant increase in the number of available complete microbial and viral genome sequences and, consequently, to increasing use of DNA sequence analysis in clinical microbiology laboratories, where the results may be influential on consequent patient management. The evolution of Sangerbased technologies is now being complemented by the revolution of second- and third-generation sequencing technologies that, potentially, could provide whole-microbial-genome analysis at the clinical bench and have a greater, more direct impact on patient and outbreak management. While the technologies have continued to evolve, common standards for the description of DNA sequence data quality still do not exist. Further, utilization of DNA sequence data requires comparison with other similar sequence data held in private or public databases. Similarly, there is no process for the accreditation of these databases and the analyses that they provide to ensure that they are fit for purpose. We strongly urge that action is required to address this. CURRENT USES OF SEQUENCING IN CLINICAL MICROBIOLOGY DNA sequencing is being introduced into microbial diagnosis particularly for the identification of esoteric organisms where traditional methods fail or where the delay to definitive identification by traditional means is significant to patient treatment. The most common locus used for bacterial identification is the 16S rRNA gene (6). In general, the complete sequence data rather than individual bases are important when making comparisons to existing data to make the identification. Other loci, in particular rpoB and gyrB (19, 31), are often used for genera whose species are more difficult to resolve with the 16S locus. Because the identification may be used in clinical management to alter treatment regimens, the quality of the data used to make this identification is crucial. Sequence-based typing methodologies, typified by multilocus sequencing typing (MLST), are often used for typing in epidemiological studies and population biology. The results do not usually have a clinical impact in the short term but may be of great importance in medico-legal cases when identifying source of infection, and therefore data quality is essential. Crucially, with these techniques, a single-base change alters the type; therefore, the quality at individual bases is as relevant as

News and Notes

News and Notes

1561 NO RESIDUAL TUMOR (PT0) AT RADICAL PROSTATECTOMY IN CLINICAL T1A-B PROSTATE CANCER. DEVELOPMENT OF A NOVEL AND USER-FRIENDLY PREDICTING TOOL

You have accessJournal of UrologyProstate Cancer: Localized VI1 Apr 20101561 NO RESIDUAL TUMOR (PT0) AT RADICAL PROSTATECTOMY IN CLINICAL T1A-B PROSTATE CANCER. DEVELOPMENT OF A NOVEL AND USER-FRIENDLY PREDICTING TOOL Umberto Capitanio, Alberto Briganti, Vincenzo Scattoni, Andrea Salonia, Marco Bianchi, Manuela Tutolo, Giovanni Lughezzani, Pierre Karakiewicz, Massimo Freschi, Patrizio Rigatti, and Francesco Montorsi Umberto CapitanioUmberto Capitanio Milan, Italy More articles by this author , Alberto BrigantiAlberto Briganti Milan, Italy More articles by this author , Vincenzo ScattoniVincenzo Scattoni Milan, Italy More articles by this author , Andrea SaloniaAndrea Salonia Milan, Italy More articles by this author , Marco BianchiMarco Bianchi Milan, Italy More articles by this author , Manuela TutoloManuela Tutolo Milan, Italy More articles by this author , Giovanni LughezzaniGiovanni Lughezzani Milan, Italy More articles by this author , Pierre KarakiewiczPierre Karakiewicz Montreal, Canada More articles by this author , Massimo FreschiMassimo Freschi Milan, Italy More articles by this author , Patrizio RigattiPatrizio Rigatti Milan, Italy More articles by this author , and Francesco MontorsiFrancesco Montorsi Milan, Italy More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2010.02.1326AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Absence of residual tumor at radical prostatectomy (pT0) is a non-negligible issue in patients with incidental prostate cancer (cT1a-cT1b) after surgery for benign prostatic hyperplasia (SxBPH). However, no tool predicting the absence of residual tumor at pathological assessment is currently available. METHODS The study included 158 consecutive cT1a-b prostate cancer patients treated with RP (1996-2009) at a single tertiary referral center. All patients had complete clinical and pathological data. A novel risk stratification tool was developed applying the tree modeling technique of classification and regression tree analysis (CART). The tool automatically selected the most informative predictors among all the obtainable variables (age,PSA at SxBPH, PSA after SxBPH, cT1a-b stage, prostate volume before and SxBPH, Gleason sum at SxBPH). The area under the receiver characteristic curve (AUC) method was used to quantify the predictive accuracy of the model which was internally validated with two hundred bootstrap resamples. RESULTS Median age at prostate cancer (PCa) diagnosis was 66 years. Overall, 95 (60.1%) patients were staged cT1a while the remaining 63 (39.9%) had cT1b PCa. Mean and median PSA before SxBPH was 5.7 and 4.2 ng/ml, while mean and median PSA after SxBPH was 1.7 and 1.1 ng/ml, respectively. Median prostate volume before and after SxBPH was 58 cc and 30.5 cc, respectively. Overall, 21 patients (13.9%) showed no residual tumor (pT0) at RP. Three risk groups of having pT0 disease at RP were identified a) Low risk: PSA after SxBPH> 1.0 ng/ml (risk of pT0, 3.8%); b) Intermediate risk: PSA after SxBPH <1.0 ng/ml and PSA before SxBPH >2.0 ng/ml (risk of pT0: 14.8%); c) High risk: PSA after SxBPH <1.0 ng/ml and PSA before SxBPH <2.0 ng/ml (high risk group, 42.3%). The bootstrap-corrected accuracy of the proposed model was 77.1%. CONCLUSIONS No residual tumor (pT0) at RP in patients with cT1a-T1b PCa is a non-negligible entity. However, the rate if pT0 is significantly associated with the levels of PSA before and after SxBPH. Stage (cT1a vs. cT1b) does not improve the ability to predict pT0. We provided a user-friendly, accurate and clinically useful flow chart to predict the absence of residual tumor at RP after diagnosis of incidental prostate cancer. © 2010 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 183Issue 4SApril 2010Page: e603 Advertisement Copyright & Permissions© 2010 by American Urological Association Education and Research, Inc.MetricsAuthor Information Umberto Capitanio Milan, Italy More articles by this author Alberto Briganti Milan, Italy More articles by this author Vincenzo Scattoni Milan, Italy More articles by this author Andrea Salonia Milan, Italy More articles by this author Marco Bianchi Milan, Italy More articles by this author Manuela Tutolo Milan, Italy More articles by this author Giovanni Lughezzani Milan, Italy More articles by this author Pierre Karakiewicz Montreal, Canada More articles by this author Massimo Freschi Milan, Italy More articles by this author Patrizio Rigatti Milan, Italy More articles by this author Francesco Montorsi Milan, Italy More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...

A Wandering Pancreatic Mass

Picture 1. The first contrast-enhanced CT scan showed a large mass of 57 mm in size with heterogeneous contrast enhancement in the head to body of the pancreas on the right side of the aorta (A). Two months after the first CT, a CT scan performed before surgery showed a shift of the large mass to the body to tail of the pancreas on the left side of the aorta (B). □ PICTURES IN CLINICAL MEDICINE □

Orbital Abscess Associated with Sinusitis from Odontogenic Origin

Picture 2. Contrast-enhanced cranio-orbital CT-scan: Axial view (A) and sagital reconstruction (B) revealing a large orbital abscess on the left side (star) with intraorbital celulitis and spheno-ethmoidal sinusitis. Picture 3. Orbital MRI on T1-weighted image with gadolinium injection (coronal view) revealing a large ring-enhancing cystic mass in the left orbit (star) with severe indentation of the eyebal and temporal extension. Note the paranasal sinus inflammation. □ PICTURES IN CLINICAL MEDICINE □

Posterior Cerebral Artery Territory Infarction Associated with Persistent Primitive Hypoglossal Artery with Internal Carotid Artery Atherosclerosis

Picture 1. (a) T2-weighted brain MRI showing a hyperintense lesion in the right posterior cerebral artery (PCA) territory. Difusion-weighted brain MRI showing no hyperintense lesions (figure not shown). (b, c) Brain MR angiography demonstrating right persistent primitive persistent hypoglossal artery (PPHA) originating from the right internal carotid artery (ICA) to the basilar artery. Bilateral vertebral arteries appeared hypoplastic and almost al the blood flow to the basilar artery was supplied by PPHA. (d) Carotid ultrasonography demonstrating iso-echoic plaque of 2 mm at the origin of the right ICA (white arrow). □ PICTURES IN CLINICAL MEDICINE □

THE ACCURACY OF TRANSRECTAL ULTRASONOGRAPHY IN CLINICAL STAGING OF PROSTATE CANCER

You have accessJournal of Urology1 Apr 2008THE ACCURACY OF TRANSRECTAL ULTRASONOGRAPHY IN CLINICAL STAGING OF PROSTATE CANCER Michael L Eisenberg, Peter R Carroll, and Katsuto Shinohara Michael L EisenbergMichael L Eisenberg More articles by this author , Peter R CarrollPeter R Carroll More articles by this author , and Katsuto ShinoharaKatsuto Shinohara More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(08)60332-8AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "THE ACCURACY OF TRANSRECTAL ULTRASONOGRAPHY IN CLINICAL STAGING OF PROSTATE CANCER." The Journal of Urology, 179(4S), p. 116 © 2008 by American Urological AssociationFiguresReferencesRelatedDetails Volume 179Issue 4SApril 2008Page: 116 Advertisement Copyright & Permissions© 2008 by American Urological AssociationMetricsAuthor Information Michael L Eisenberg More articles by this author Peter R Carroll More articles by this author Katsuto Shinohara More articles by this author Expand All Advertisement PDF downloadLoading ...

Public Disclosure in Research with Exception from Informed Consent: The Use of Survey Methods to Assess its Effectiveness

IN CLINICAL TRIALS WITH EXCEPTION from informed consent, the Final Rule stipulates that investigators inform and consult with the community. A random-digit-dialing survey of 200 individuals assessed the effectiveness of public disclosure via press releases, notices in local newspapers, local radio and television stations and the host hospital's website, as well as a series of community meetings regarding a pending clinical trial of this kind. Results showed a 10% awareness level of the public trial, which is higher than surveys using convenience samples. Understanding of the nature of the trial was generally poor, while opinions about participating in this type of research were more favorable among individuals aware of the trial. Our findings suggest that adherence to the intent of the Final Rule is dependent on uniform guidelines for what constitute effective public disclosure methods and adequate community awareness and understanding and the use of rigorous sampling methods for evaluation.

Magnetic Resonance Images in Rhombencephalitis Due to Listeria monocytogenes Mimicking Wernicke Encephalopathy

Figure 1. Fluid-atenuated inversion recovery (FLAIR) images of the brain (TR: 8,000 msec, TE: 120 msec) show symmetric high signal intensity in the rostral midbrain on day 10 (A, C). Hydrocephalus and periventricular high intensities are also evident. On day 17, FLAIR images show markedly reduced high signal intensity in the midbrain except for the periaqueductal gray mater (B, D). □ PICTURES IN CLINICAL MEDICINE □

The need for accurate statistical reporting. A commentary on “Guidelines for reporting statistics in journals published by the American Physiological Society: the sequel”

i think it obvious that authors should be required to report their statistical analyses accurately and completely and that the standard error of the mean (SEM) should not be used when other statistics are more appropriate. To argue otherwise is to promote a lower standard of research. Although an

How should we achieve high-quality reporting of statistics in scientific journals? A commentary on “Guidelines for reporting statistics in journals published by the American Physiological Society”

some disturbing news was reported in the March 2005 issue of Significance , a publication of the Royal Statistical Society ([7][1]). Based on a variety of audits, it was found that 38% of the articles published in 2001 in Nature contained some statistical “incongruence”: a disparity between

MOLLISON'S BLOOD TRANSFUSION IN CLINICAL MEDICINE, 11TH ED.

TransfusionVolume 47, Issue 3 p. 551-551 MOLLISON'S BLOOD TRANSFUSION IN CLINICAL MEDICINE, 11TH ED. Paul M. Ness MD, Paul M. Ness MD Editor, TRANSFUSION Search for more papers by this authorR. Sue Shirey MS, MT(ASCP)SBB, R. Sue Shirey MS, MT(ASCP)SBB Assistant Editor Search for more papers by this author Paul M. Ness MD, Paul M. Ness MD Editor, TRANSFUSION Search for more papers by this authorR. Sue Shirey MS, MT(ASCP)SBB, R. Sue Shirey MS, MT(ASCP)SBB Assistant Editor Search for more papers by this author First published: 21 February 2007 https://doi.org/10.1111/j.1537-2995.2007.01153.xRead the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Volume47, Issue3March 2007Pages 551-551 RelatedInformation

IMPLICATIONS OF LOW GREAT TOE PRESSURES IN CLINICAL PRACTICE

The aim of this study was to observe the outcome of patients with a great toe pressure (GTP) reading of less than 40 mmHg. Between 2002 and 2004, of 4,714 patients assessed in the Westmead Vascular Laboratory, 365 (7.7%) had GTP measurements for assessment of possible critical limb ischaemia. There were 56 limbs in 40 patients with a GTP measurement of less than 40 mmHg, and this group was studied to assess outcome factors of death, requirement for major or minor amputation, arterial reconstructive surgery, clinical stability, or documented improvement from the initial assessment. Patients requiring a major amputation had an average GTP of 13 mmHg and a toe brachial index (TBI) of 0.08, whereas those not undergoing a major amputation had an average GTP of 23.6 mmHg and TBI of 0.15. This association was weaker when an initial single evaluation was used as opposed to two or more serial assessments. Patients with and without a major amputation had an average ankle brachial index of 0.16 and 0.53, respectively. Diabetes mellitus requiring insulin and cerebrovascular disease were risk factors for major amputations. Low GTP was associated with a greater risk of major amputations. Two or more serial assessments were found to be of greater value than an initial single assessment.

Miscellaneous: Electrophoresis 10‐11/2004

ELECTROPHORESISVolume 25, Issue 10-11 p. 1726-1726 Miscellaneous Miscellaneous: Electrophoresis 10-11/2004 First published: 02 June 2004 https://doi.org/10.1002/elps.200490015AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article. Volume25, Issue10-11Special Issue: Paper Symposium CAPILLARY ELECTROPHORESIS IN CLINICAL AND FORENSIC ANALYSISNo. 10‐11 June 2004Pages 1726-1726 RelatedInformation